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Abstract
Objectives: To explore the supportive care needs of cancer survivors, the
characteristics of patients with high levels of unmet need, changes in unmet need
after treatment ends and differences in unmet needs of breast, colorectal and
testicular survivors.
Methods: The method used was a prospective longitudinal mailed survey. Unmet
needs, measured by 25-item modified Cancer Survivors Unmet Needs survey at
baseline (immediately post-treatment) and 8 months later, were analysed
descriptively.
Results: Of 434 breast, 186 colorectal and 75 testicular patients responding at
baseline, 56.2%, 65.6% and 50.7%, respectively, had no unmet needs, the top decile
having ≥10 (breast) or seven (colorectal and testicular) different needs and seven
different unmet needs. The most frequently reported unmet need (all groups) was
fear of cancer recurrence. Unmet needs fell significantly at 8 months for breast
patients. Some patients reported new needs. Needs were lowest amongst colorectal
survivors and differed between the three groups. Higher levels of unmet needs
(breast and colorectal) were associated with having had chemotherapy.
Conclusion: Most survivors reported few unmet needs, but a small proportion have
persisting or emerging needs. Routine or regular monitoring of unmet needs is
required so that healthcare professionals can deliver personalised care based on
individual needs, preferences and circumstances.
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1 | INTRODUCTION
Improvements in early detection and more effective treatments have
led to increased cancer survival rates in most regions of the world
(Allemani et al., 2018). However, this population of cancer survivors
(Macmillan Cancer Support, 2017) may experience detrimental
impacts on quality of life, psychological morbidity and unmet needs as
a result of their cancer and treatment (Palmer et al., 2017; Smith
et al., 2018). This paper focusses on unmet supportive care needs that
were reported by breast, colorectal and testicular cancer survivors.
The data were gathered as part of a larger study (Batehup et al., 2017)
that was conducted at a time when policy and practice regarding
follow-up after cancer treatment in the British National Health Service
(NHS) was changing (Davies & Batehup, 2011). A shift was proposed
from traditional hospital clinic-based follow-up for all patients to
patient stratification, based on a clinical assessment of individual
patient needs. Patients judged to have ongoing problems or complex
conditions continued to receive clinic follow-up whilst others are pro-
vided with information for self-management and the opportunity to
contact specialist nurses by telephone with their concerns and
questions (patient triggered follow-up). All usual surveillance tests
continue (http://www.evidence.nhs.uk/qipp). This change was largely
prompted by resourcing pressures in hospital outpatient departments
that were increasing waiting times for cancer treatment (Davies &
Batehup, 2011). Whilst there is little evidence that clinic follow-up
improves recurrence detection rates (Centre for Reviews and
Dissemination, 2007; Kimman et al., 2007; Montgomery et al., 2007),
concerns exist that removal or reduction of outpatient attendance
may increase anxiety amongst survivors and result in their needs not
being addressed (Chapman et al., 2009). Hence, the unmet supportive
care needs of survivors in three tumour groups within a large cancer
centre in United Kingdom were evaluated to inform future service
developments. Breast and colorectal pathways were selected because
these are high volume services; testicular patients were added
because they are an under-researched group.
Available evidence on unmet needs of cancer survivors is inconclu-
sive (Harrison et al., 2009; Harrison et al., 2010; Willems et al., 2015;
Wylie et al., 2013), and little comparative information is available. This
paper reports findings from a study that aimed to improve understand-
ing of unmet needs to inform practice through (1) an assessment of the
prevalence of different types of unmet needs reported by breast,
colorectal and testicular cancer survivors at completion of treatment and
how these changed over the subsequent 8 months and (2) an investiga-
tion of the characteristics of survivors reporting high levels of unmet
need so that support can be targeted. The study also enabled a compari-
son of the unmet needs of breast, colorectal and testicular survivors.
2 | METHODS
A longitudinal survey of breast, colorectal and testicular cancer patients
was carried out in two cohorts (before and after the introduction of
patient triggered follow-up) between April 2011 and August 2013.
Salient details can be found elsewhere (Batehup et al., 2017). Almost all
(90%) of those in the patient triggered follow-up cohort were receiving
outpatient follow up at the start of the study so the cohorts were com-
bined for the analysis. Researchers used a review of records, including
chemotherapy and radiotherapy treatments and multidisciplinary team
meetings to identify patients aged 18 years and over who were coming
to completion of treatment with curative intent and entering follow-up.
Permission was obtained from clinicians to approach their patients.
Patients were excluded if they were unable to complete the necessary
questionnaires or had a second cancer diagnosed during treatment.
Informed consent was obtained from all individual participants.
Approval was obtained from the Ethics Committee of the NHS Trust
involved. Guidance from the National Research Ethics Service advised
this was a service evaluation. The procedures in this study adhere to
the tenets of the Declaration of Helsinki.
Structured questionnaires were mailed to patients after final
treatment (T0) and four (T1), eight (T2) and 12 (T3) months later.
Three reminders were sent to non-responders. Only responses at T0
and T2 are included in this paper. Participants' experience at these
points reflect needs after primary treatment and over a period when
awareness of emotional and psychosocial effects of cancer survivor-
ship grows. Some participants recruited at the end of the project were
not sent questionnaires at T2, and some questionnaires that were sent
and returned were not analysed due to study time constraints,
thereby reducing the sample size at T2.
2.1 | Baseline questionnaire and data collection
Participant demographics were collected at baseline, including gender,
age, relationship status, education, employment status and comorbid
conditions. Clinical information on treatments received, dates and
recurrences, were extracted from clinical notes (with consent). Post-
code was used to derive the Index of Multiple Deprivation (Ministry
of Housing, Communities and Local Government, Office of National
Statistics, Index of Multiple Deprivation, 2015).
2.2 | Measuring supportive care needs
Supportive care needs in the preceding month were measured at each
time point using the Cancer Survivors Unmet Needs Survey (CaSUN)
(Hodgkinson et al., 2007). In its original form, it comprises 35 items,
but following Willems et al. (2015) and Amatya et al. (2014), the study
focused on the 28 items in five domains relating to need. Following
piloting with patients, the 28 items were reduced to 25. Domains,
items and scoring are described in Table 1.
2.3 | Statistical analysis
Characteristics of patients were compared at T0 between the three
cancer types and between those recruited in the two cohorts (pre and
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post the introduction of patient triggered follow-up). Participants at
T2 were compared with non-responders. The total number of unmet
needs (any strength) was aggregated (range 0–25; higher scores
indicating more unmet needs) for each participant. Within each cancer
type, unmet needs of any strength were aggregated by CaSUN
domain, and domain totals were compared between tumour groups at
TABLE 1 Cancer survivors unmet supportive care needs survey
Item number Domain Item, CaSUN Need Description I need:
1 Information (INFO) Up to date information
2 Information relevant for my partner/family
3 Understandable information
4 Comprehensive Cancer Care (CCC) The very best medical care
5 Local health services available when I
require them
6 To feel I can manage my health together
with my health team
7 My doctors to talk to each other to
coordinate my care
8 My complaints regarding my care to be
properly addressed
9 Existential Survivorship (ES) To reduce stress in my life
10 Help to cope with my concerns that my
cancer will recur
11 Emotional support for me
14 To make new relationships
15 To talk to other survivors like me
16 Help to handle the topic of cancer in social/
work situation
17 To adjust to changes to the way I feel about
my body
12 Relationships (REL) To know how to support my family/partner
13 Help to deal with the impact of cancer on
my relationships
18 Help to deal with problems with my sex life
19 Coping (COP) To move on with my life
20 To deal with my belief that nothing bad will
happen again
21 For others to acknowledge the impact of
cancer on my life
22 Help to cope with others' expectations of
me as a survivor
23 To make decisions about my life in
uncertain times
24 Help with my spiritual beliefs
25 To make my life count
Note: Response options for each item were as follows: Not applicable; No need; I have the need, but it is being met; Yes, I have the need and it is not being
met (i.e., an unmet need). Three items were omitted from the 28 items assessing need: reference to car parking was removed from the Comprehensive
Cancer Care domain because patients found it irrelevant. The two items comprising the Quality of Life domains were dropped because quality of life was
measured by other instruments in the parent study. A new Coping domain was created with seven items from the 14 items Existential Survivorship
domain. Unmet needs were rated Strong/Moderate/Weak. Scoring and interpretation of CaSUN was carried out according to published guidance
(Hodgkinson et al., 2007). As domains contain different numbers of items, the mean number of needs were analysed. Missing CaSUN items were recoded
as follows for calculating domain and total unmet needs: within each of the five domains where at least one, but not all, items were completed, each
missing item was set equal to the proportion of unmet needs amongst the non-missing items in that domain. If only one domain had all items missing, each
item was assigned the proportion of unmet needs amongst all non-missing items in the other four domains. If two or more domains had all items missing,
these domains and the total unmet needs were set as missing (irrespective of how many of the 25 items had been answered).
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T0. Individuals with the highest levels of unmet needs were defined
through inspection of the distribution of the number of unmet needs
(any strength) in each tumour group. These highest need individuals
were identified at T0 and T2 and compared with the remainder of
respondents regarding baseline socio-demographic and clinical charac-
teristics. Comparisons were conducted using tests appropriate to type
of variable.
Responses from patients who had participated both at T0 and T2
were analysed to assess the changes to unmet needs (any strength)
between T0 and T2. Four categories of unmet needs were identified:
persistent (present at T0 and T2), emergent (not present at T0,
present at T2), resolved (present at T0, not present at T2) and none
(neither present at T0 nor T2). Numbers and percentages were
tabulated for each item, for each tumour site. Changes in the total
unmet needs from T0 to T2 were reported as means with 95%
confidence intervals; changes within tumour sites were assessed
(paired t test). Statistical significance was reported at the 5% level
throughout.
3 | RESULTS
3.1 | Baseline characteristics of participants
Of 1410 breast, colorectal and testicular patients screened for the
study, 1316 were eligible and sent baseline questionnaire. Of these,
948 (72%) were returned, and 878 (66.7%) analysed. A detailed
recruitment table is shown in Figure 1.
Baseline characteristics of participants are shown in Table 2.
Amongst non-clinical features, testicular cancer survivors, as com-
pared with colorectal and breast participants were more likely to have
had higher education (Kruskal–Wallis test: p = 0.001), were less likely
F IGURE 1 Recruitment flow chart (April 2010
to August 2013) for all patients combined (breast,
colorectal and testicular)
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to live alone (chi-squared test: p = 0.045) and had fewer long standing
illnesses (Kruskal–Wallis test: p < 0.001). Chemotherapy was more
common amongst testicular survivors (81.6%) (breast 31.1%,
colorectal 30.7%) (chi-squared test: p < 0.001). Comparison of the
characteristics of the two cohorts (pre and post the introduction of
patient triggered follow-up) found no difference.
3.2 | Unmet needs at T0
Amongst the 434 breast, 186 colorectal and 75 testicular cancer par-
ticipants who completed all 25 CaSUN items, 56.2% (95% CI: 51.5%
to 60.9%), 65.6% (95% CI: 58.7% to 72.5%) and 50.7% (95% CI:
39.1% to 62.2%), respectively, had no unmet needs at T0. The mean
(SD) total number of unmet needs (any strength) at T0 was 2.74 (4.64)
for breast, 1.71 (3.49) for colorectal and 2.01 (3.12) for testicular
cancer. Most frequently reported unmet need for all tumour sites was
fear of cancer recurrence (24.4% breast, 13.7% colorectal and 22.0%
testicular) (Table 3).
Breast and testicular participants experienced significantly higher
unmet needs over colorectal in the Existential Survivorship and
Coping domains (Kruskal–Wallis test: p = 0.010, 0.003, respectively);
there was no statistically significant difference in unmet needs across
the tumour sites in the Information, Comprehensive Cancer Care and
Relationships domains. Item analysis revealed that fear of cancer
recurrence and managing stress (both Existential Survivorship domain)
and coping with others' expectations and decision making about the
future (both Coping domain) contributed to the higher unmet needs of
breast and testicular participants. A statistically significant (chi-square
test: p = 0.012) higher percentage of breast participants over colorec-
tal and testicular experienced unmet need regarding adjustment to
body changes (Existential Survivorship domain) (Table 3).







Participant demographics (Time T0a)
Age in years, mean (SDb) 61.2 (11.6) 72.0 (10.1) 39.1 (12.2)
Ethnicity = White (n, %) 520 (97.6%) 241 (98.8%) 86 (98.9%)
Domestic status = live with spouse/partner vs. live alone, live with others, or other (n, %) 368 (69.4%) 163 (67.9%) 56 (65.9%)
Deprivation index mean (SD) [range: 1–32,482; 1 is highest] 21,550 (8046) 20,307 (9082) 19,888 (7668)
Gender = female (n, %) 539 (99.8%) 101 (40.2%) 0 (0%)
Highest education qualification (n, %) No qualifications 128 (25.7%) 81 (37.3%) 12 (14.0%)
GCSEs [age 16] 128 (25.7%) 33 (15.2%) 19 (22.1%)
A-level [age 18] 34 (6.8%) 18 (8.3%) 8 (9.3%)
Vocational qualification 133 (26.7%) 57 (26.3%) 27 (31.4%)
University graduate 76 (15.2%) 28 (12.9%) 20 (23.3%)
Clinical
Months, first diagnosis to T0, mean (SD) 6.61 (5.07) 6.83 (4.04) 5.17 (3.93)
Months, end of last treatment to T0, mean (SD) 1.88 (1.47) 4.43 (2.41) 2.54 (1.73)
Number of long-term conditions mean (SD) 0.80 (1.03) 1.00 (1.11) 0.25 (0.65)
Treatments (n, %)
Surgery only 45 (8.3%) 168 (66.9%) 13 (14.9%)
Surgery + chemotherapy 7 (1.3%) 54 (21.5%) 70 (80.5%)
Surgery + radiotherapy 26 (4.8%) 6 (2.4%) 3 (3.4%)
Surgery + chemotherapy + radiotherapy 27 (5.0%) 22 (8.8%) 0 (0%)
Surgery + hormone therapy 85 (15.7%) 0 (0%) 0 (0%)
Surgery + radiotherapy + hormone therapy 216 (40.0%) 0 (0%) 0 (0%)
Surgery + chemotherapy + radiotherapy + hormone therapy 71 (13.1%) 0 (0%) 0 (0%)
Surgery + chemotherapy + radiotherapy + trastuzumab 34 (6.3%) 0 (0%) 0 (0%)
Surgery + chemotherapy + hormone therapy + trastuzumab 28 (5.2%) 0 (0%) 0 (0%)
Chemotherapy + hormone therapy + trastuzumab 1 (0.2%) 0 (0%)
Chemotherapy only 1 (1.1%)
Surgery + chemotherapy + microwave ablation 0 (0%) 1(0.4%) 0 (0.0%)
aCompletion of primary treatment (Baseline T0).
bStandard deviation.
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TABLE 3 Changes in weak/moderate/strong unmet needs between T0 and T2 ranked according to the proportion with weak/moderate/



























Breast (n = 312 returned survey at T0 and T2)
ES 1 1 Help to cope with my
concerns that my
cancer will recur
73 (24.4) 57 (18.9) 290 38 (13.1) 31 (10.7) 22 (7.6) 199 (68.6)
ES 3 2 Help to reduce the
stress in my life
51 (16.9) 44 (14.6) 283 23 (7.8) 26 (8.9) 17 (5.8) 227 (77.5)
CCC 8 3 My doctors to talk to
each other to
coordinate my care
41 (13.7) 39 (13.2) 287 21 (7.3) 18 (6.3) 19 (6.6) 229 (79.8)
ES 11 4 Emotional support for
me
38 (12.8) 38 (12.6) 289 20 (6.9) 14 (4.8) 23 (8.0) 232 (80.3)




54 (17.8) 37 (12.3) 294 28 (9.5) 24 (8.2) 11 (3.7) 231 (78.6)
COPING 5 6 Help to move on with
my life
47 (15.3) 34 (11.3) 297 21 (7.1) 21 (7.1) 11 (3.7) 244 (82.2)
ES 4 7 Help to adjust to
changes to the way
I feel about my
body
47 (15.4) 34 (11.2) 299 24 (8.0) 21 (7.0) 12 (4.0) 242 (82.1)




44 (14.5) 33 (10.9) 296 21 (7.1) 20 (6.8) 12 (4.1) 243 (82.1)




43 (14.1) 33 (10.9) 297 21 (7.1) 19 (6.4) 10 (3.4) 247 (83.2)




39 (12.8) 33 (10.9) 297 14 (4.7) 22 (7.4) 8 (2.7) 253 (85.2)
COPING 9 11 Help to make my life
count
39 (12.9) 33 (10.8) 298 15 (5.0) 23 (7.7) 9 (3.0) 251 (84.2)




25 (8.3) 29 (9.8) 290 16 (5.5) 8 (2.8) 20 (6.9) 246 (84.8)
REL 14 13 Help to deal with
problems with my
sex life
34 (11.4) 26 (8.7) 292 16 (5.5) 16 (5.5) 8 (2.7) 252 (86.3)
REL 12 14 Help to deal with the
impact of cancer
on my relationships
35 (11.8) 24 (7.9) 292 22 (7.5) 13 (4.5) 10 (3.4) 247 (84.6)




31 (10.3) 23 (7.7) 290 20 (6.9) 10 (3.4) 12 (4.1) 248 (85.5)




31 (10.4) 22 (7.4) 286 22 (7.7) 8 (2.8) 13 (4.5) 243 (85.0)




























CCC 19 17 The very best medical
care
26 (8.7) 21 (7.1) 284 16 (5.6) 7 (2.5) 12 (4.2) 249 (87.7)
REL 13 18 Help to know how to
support my family/
partner
35 (11.7) 21 (7.0) 291 23 (7.9) 10 (3.4) 10 (3.4) 248 (85.2)
ES 17 19 To talk to other
breast cancer
survivors like me
31 (10.2) 19 (6.3) 289 21 (7.0) 8 (2.7) 10 (3.3) 260 (87.0)
INFO 18 20 Up to date
information
28 (9.5) 17 (5.6) 287 21 (7.3) 6 (2.1) 9 (3.1) 251 (87.5)
INFO 21 21 Understandable
information
22 (7.5) 16 (5.4) 286 17 (5.9) 4 (1.4) 9 (3.1) 256 (89.5)
COPING 24 22 Help with my spiritual
beliefs
16 (5.2) 15 (4.9) 301 9 (3.0) 6 (2.0) 9 (3.0) 277 (92.0)
ES 22 23 Help to handle the
topic of cancer in
social/work
situation
22 (7.2) 11 (3.6) 298 16 (5.4) 5 (1.7) 6 (2.0) 271 (90.9)
INFO 23 24 Information relevant
for my partner/
family
16 (5.4) 11 (3.6) 289 12 (4.2) 4 (1.4) 5 (1.7) 268 (92.7)
ES 25 25 Help to make new
relationships
12 (3.9) 11 (3.6) 302 7 (2.3) 5 (1.7) 6 (2.0) 284 (94.0)
Colorectal (n = 132 returned survey at T0 and T2)
CCC 3 1 Local health services
available when I
require them
14 (11.2) 13 (11.0) 113 7 (6.2) 4 (3.5) 9 (8.0) 93 (82.3)
ES 11 2 Help to reduce the
stress in my life
10 (7.9) 12 (10.0) 116 4 (3.4) 3 (2.6) 9 (7.8) 100 (86.2)
CCC 15 3 The very best medical
care
8 (6.6) 12 (9.8) 114 5 (4.4) 2 (1.8) 9 (7.9) 98 (86.0)
ES 1 4 Help to cope with my
concerns that my
cancer will recur
17 (13.7) 11 (9.2) 113 9 (8.0) 4 (3.5) 7 (6.2) 93 (82.3)




9 (7.2) 11 (9.1) 114 5 (4.4) 1 (0.9) 10 (8.8) 98 (86.0)




10 (8.3) 10 (8.3) 111 52 (1.8) 2 (1.8) 7 (6.3) 97 (87.4)
CCC 2 7 My doctors to talk to
each other to
coordinate my care
17 (13.6) 10 (8.2) 117 9 (7.7) 6 (5.1) 4 (3.4) 98 (83.8)




10 (7.9) 9 (7.1) 122 4 (3.3) 5 (4.1) 4 (3.3) 109 (89.3)
REL 8 9 Help with problems
with my sex life
10 (8.0) 9 (7.0) 121 4 (3.3) 6 (5.0) 3 (2.5) 108 (89.3)
INFO 7 10 Up to date
information
10 (8.1) 8 (6.6) 118 6 (5.2) 3 (2.6) 5 (4.3) 101 (87.8)
(Continues)
































10 (8.0) 8 (6.3) 119 5 (4.2) 4 (3.4) 4 (3.4) 106 (89.1)
COPING 19 12 Help to make my life
count
6 (4.8) 8 (6.3) 120 4 (3.3) 2 (1.7) 6 (5.0) 108 (90.0)
INFO 4 13 Understandable
information
13 (10.5) 6 (5.0) 113 8 (7.1) 2 (1.8) 4 (3.5) 99 (89.6)
INFO 24 14 Information for
family/others
4 (3.2) 6 (5.0) 115 2 (1.7) 2 (1.7) 4 (3.5) 107 (93.0)
ES 12 15 To talk to other
colorectal survivors
like me
10.7.9) 6 (4.8) 119 6 (5.0) 3 (2.5) 3 (2.5) 107 (89.9)
ES 5 16 Emotional support for
me
11 (8.7) 6 (4.8) 120 8 (6.7) 2 (1.7) 4 (3.3) 106 (88.3)




10 (8.0) 6 (4.8) 119 4 (3.4) 5 (4.2) 1 (0.8) 109 (91.6)
COPING 21 18 Help to move on with
my life
7 (5.6) 6 (4.8) 120 5 (4.1) 2 (1.7) 4 (3.3) 110 (92.5)
ES 18 19 Help to adjust to
changes to the way
I feel about my
body
7 (5.6) 6 (4.7) 121 5 (4.1) 2 (1.7) 4 (3.3) 110 (90.9)




8 (6.4) 5 (4.0) 117 2 (1.7) 4 (3.4) 1 (0.9) 110 (94.0)
REL 20 21 Help to know how to
support my
partner/family
6 (4.8) 5 (4.0) 120 4 (3.3) 2 (1.7) 3 (2.5) 111 (92.5)
ES 25 22 Help to make new
relationships
4 (3.2) 5 (3.9) 121 2 (1.7) 2 (1.7) 3 (2.5) 114 (94.2)
REL 22 23 Help to deal with the
impact of cancer
on my relationships
5 (4.0) 4 (3.2) 122 3 (2.5) 2 (1.6) 2 (1.6) 115 (94.3)
COPING 23 24 Help with my spiritual
beliefs
5 (4.0) 3 (2.4) 121 4 (3.3) 0 (0.0) 3 (2.5) 114 (94.2)
ES 16 25 Help to handle the
topic of cancer in
social/work
situation
7 (5.6) 2 (1.6) 119 5 (4.2) 1 (0.8) 1 (0.8) 112 (94.1)
Testicular (n = 41 returned survey at T0 and T2)
ES 1 1 Help to cope with my
concerns that my
cancer will recur
9 (22.0) 6 (14.6) 41 5 (12.2) 4 (9.8) 2 (4.9) 30 (73.2)
ES 2 2 Help to reduce stress
in my life
6 (15.0) 5 (12.5) 39 4 (10.3) 2 (5.1) 3 (7.7) 30 (76.9)
REL 8 3 Help with problems
with my sex life
4 (10.0) 4 (10.3) 39 4 (10.3) 0 (0.0) 4 (10.3) 31 (79.5)




























ES 10 4 To talk to other
testicular cancer
survivors like me
3 (7.5) 4 (10.0) 39 1 (2.6) 2 (5.1) 2 (5.1) 34 (87.2)
COPING 15 5 Help to move on with
my life
3 (7.3) 4 (10.0) 40 2 (5.0) 1 (2.5) 3 (7.5) 34 (85.0)




2 (5.1) 4 (10.0) 39 1 (2.6)) 1 (2.6) 2 (5.1) 35 (89.7)
CCC 7 7 My doctors to talk to
each other to
coordinate my care
4 (10.0) 4 (9.8) 40 3 (75.0) 1 (2.5) 3 (7.5.) 33 (87.5)
ES 9 8 Emotional support for
me
4 (9.8) 4 (9.8) 41 3 (7.3) 1 (2.4) 3 (7.3) 34 (82.9)
COPING 4 9 Help to make
decisions in
uncertain times
6 (14.6) 3 (7.5) 40 4 (10.0) 2 (5.0) 1 (2.5) 33 (82.5)
ES 11 10 Help to adjust to
changes to the way
I feel about my
body
3 (7.5) 3 (7.5) 40 2 (5.0) 1 (2.5) 2 (5.0) 33 (87.5)
CCC 16 11 The very best medical
care
2 (5.1) 3 (7.5) 38 1 (2.6) 1 (2.6) 2 (5.3) 34 (89.5)
COPING 20 12 Help to make my life
count
2 (4.9) 3 (7.5) 40 1 (2.5) 1 (2.5) 2 (5.0) 36 (90.0)
REL 13 13 Help to know how to
support my
partner/family
3 (7.3) 3 (7.3) 41 1 (2.4) 2 (4.9) 1 (2.4) 37 (90.2)
REL 14 14 Help to deal with the
impact of cancer
on my relationships
3 (7.3) 3 (7.3) 41 2 (4.9) 1 (2.4) 2 (4.9) 36 (87.8)




6 (15.0) 2 (5.0) 40 5 (12.5) 1 (2.5) 1 (2.5) 33 (82.5)




5 (12.2) 2 (5.0) 40 4 (10.0) 1 (2.5) 1 (2.5) 34 (85.0)




3 (7.3) 2 (4.9) 41 2 (4.9) 1 (2.4) 1 (2.4) 37 (90.2)
INFO 22 18 Understandable
information
1 (2.5) 2 (4.9) 40 1 (2.5) 0 (0.0) 2 (5.1) 37 (97.5)
CCC 18 19 Local health services
available when I
require them
2 (5.0) 1 (2.5) 40 1 (2.6) 1 (2.6) 0 (0.0) 37 (94.9)
ES 19 20 Help to handle the
topic of cancer in
social/work
situations
2 (4.9) 1 (2.5) 40 1 (2.5) 1 (2.5) 0 (0.0) 38 (95.0)
ES 23 21 Help to make new
relationships
1 (2.4) 1 (2.5) 40 1 (2.5) 0 (0.0) 1 (2.5) 38 (95.0)
(Continues)
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Inspection of the distribution by tumour group suggested that the
number of unmet needs fell off sharply below the top decile. This high
need group comprised (to the closest whole number) 52 (10.2%)
breast, 28 (12.2%) colorectal and 10 (12.0%) testicular. These partici-
pants had at least 10, 7 and 7 different unmet needs, respectively.
Breast cancer participants in the high needs group (≥10 unmet needs),
compared with the rest (<10), were significantly younger (mean
[SD] 54.04 [10.11] vs. 61.55 [11.29] years; unpaired t test
p < 0.0005), more likely to have received chemotherapy (n = 27,
51.9% vs. n = 136, 29.6%; chi-square p = 0.001) and tended to be
more highly educated (Mann–Whitney U test p = 0.104). Colorectal
participants were also more likely to report high needs (≥7 vs. <7) if
they had received chemotherapy (n = 14, 50.0% vs. n = 60, 29.7%,
chi-square p = 0.031). No other background characteristics were sig-
nificantly associated with reporting high numbers of needs for any
tumour site.
3.3 | Participation and unmet needs at T2
Of the 540 breast, 251 colorectal and 87 testicular participants at T0,
312 (57.8%), 132 (52.6%) and 41 (47.1%), respectively, responded
promptly at T2, a total of 485 (Figure 1). There were no significant
differences between respondents and non-respondents on any
baseline features, except amongst the colorectal patients where
respondents reported a significantly higher level of education (data
not shown).
Amongst the 249 breast, 103 colorectal and 38 testicular partici-
pants who completed all 25 CaSUN items at T2, 163 (65.5%, 95% CI:
59.5% to 71.4%) breast, 74 (71.8%, 95% CI: 63.0% to 80.7%) colorec-
tal and 23 (60.5%, 95% CI: 44.2% to 76.8%) testicular had no unmet
needs. The mean (SD) total number of unmet needs (any strength) at
T2 was 2.18 (4.52) breast, 1.38 (3.65) colorectal and 1.76 (3.88)
testicular. The most frequently reported item for breast and testicular
participants remained fear of cancer recurring (18.9% and 14.6%
respectively). For colorectal participants, availability of local health
services was the most frequently reported item (11.0%), fear of recur-
rence being fourth (9.2%) (Table 3). The need to “reduce the stress in
my life” was ranked in second place at T0 by participants from all
three tumour sites.
Regarding individuals in the top decile for number of needs,
33 (11.0%) breast, 13 (10.8%) colorectal and 4 (10.0%) testicular were
found to have at least 8, 5, and 7 unmet needs, respectively. High-
needs breast cancer participants (≥8), compared with the rest (<8),
were significantly younger (mean [SD] 55.21 [9.20] vs. 61.07 [11.32]
years, unpaired t test p = 0.002) and (marginally) more likely to have
received chemotherapy (n = 15, 45.5% vs. n = 79, 29.7%, chi-square
test: p = 0.066). Colorectal participants were also more likely to
report high unmet needs (≥5 vs. <5) if they had received chemother-
apy (n = 6, 46.2% vs. n = 28, 26.2%, chi-square test: p = 0.031) and
were more highly educated (Mann–Whitney U test p = 0.020). No
other background characteristics were significantly associated with
high unmet needs for any tumour site.
Of the 52 breast cancer participants with the highest number of
unmet needs at T0, 29 completed CaSUN at T2 of whom 16 (55.2%)
remained in the top decile at T2. Similarly, 4/10 (40%) of colorectal

































4 (10.0) 1 (2.4) 40 1 (2.5) 1 (2.5) 0 (0.0) 36 (90.0)
INFO 21 23 Up to date
information
1 (2.5) 1 (2.4) 40 1 (2.5) 0 (0.0) 1 (2.5) 38 (95.0)
INFO 24 24 Information for
family/others
0 (0.0) 1 (2.4) 39 0 (0.0) 0 (0.0) 1 (2.6) 38 (97.4)
COPING 25 25 Help with spiritual
beliefs
0 (0.0) 0 (0.0) 40 0 (0.0) 0 (0.0.) 0 (0.0.) 40 (100.0)
aINFO = Information, CCC = Comprehensive cancer care, ES = Existential survivorship, REL = Relationships, COPING = Coping.
bRanks of CaSUN items: Cancer Survivors Unmet Needs questionnaire at Time 0 (T0) post completion of all curative treatments.
cRanks of CaSUN items at Time 2 (T2), 8 months after T0.
dUnmet needs at Time 0.
eUnmet needs at Time 2.
fNumber of participants completing questionnaire at both T0 and T2.
gUnmet needs at T0 but not present at T2.
hUnmet needs present at T0 and at T2.
iUnmet needs absent at T0 and present at T2.
jAbsence of unmet needs at both T0 and T2.
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3.4 | Changes in unmet needs between T0 and T2
For breast participants, there were statistically significant decreases in
unmet needs in every domain between T0 and T2, except Compre-
hensive Cancer Care; Information (p = 0.029), Existential Survivorship
(p = 0.014), Relationships (p = 0.013) and Coping (p = 0.014). There
were no statistically significant changes in any domain for colorectal
and testicular participants (Table 3). No statistically significant differ-
ence in changes (T0 to T2) were found for any domain in comparisons
between tumour sites.
Item changes (T0 to T2) are shown in Table 3. Most participants
reported no unmet needs at T0 and T2 (far right column). There is
evidence that individuals' unmet needs change over time. For
example, 38 breast cancer survivors reported fear of cancer was
resolved at T2, whilst it had become a new issue for 22 others.
However, changes in the relative importance of different needs
between T0 and T2, as shown by the rankings, are mostly marginal. A
need for doctors to talk more to each other and for emotional support
moved up the breast cancer rankings to within the top five issues at
T2. Similarly, for colorectal participants, health service availability, best
medical care and shared decision making with the clinical team
acquired increased importance at T2. Numbers in the testicular group
were small but amongst those, help with sex life emerged as an
unmet need.
4 | DISCUSSION
Understanding the nature and extent of unmet needs of cancer survi-
vors, and how these change over time, and differ between tumour
groups, is important to inform service planning and optimise care
delivery. Consistent with findings of other studies (Armes et al., 2009;
Boyes et al., 2012; Bredart et al., 2016; Valery et al., 2017; Willems
et al., 2015), respondents reported low levels of unmet needs at both
time points. Overall, levels of unmet need were lowest amongst
colorectal survivors and diminished in all three groups over time
(significantly for breast survivors). Others have also reported
higher needs experienced by breast than colorectal survivors
(Wylie et al., 2013) and falling levels of need by breast survivors
(Minstrell et al., 2008; Von Heyman-Horan et al., 2013). Within these
overall trends, there is evidence that for some individuals needs
resolve and that new needs can emerge. Routine and regular monitor-
ing of unmet needs using appropriate tools is therefore necessary so
that cancer care specialists and other health professionals can deliver
personalised care based on individual needs, preferences and
circumstances.
Fear of cancer returning was reported as the paramount unmet
need throughout and has been reported as the most common
unmet need in many other studies, including in breast, colorectal and
mixed cancer populations (Amatya et al., 2014; Armes et al., 2009;
Boyes et al., 2012; Simard et al., 2013; Valery et al., 2017). Testicular
cancer survival rates are high (Cancer Research UK, 2017), but many
men report persistent worries about recurrence (Bender et al., 2012;
Smith et al., 2013, 2018). Receiving a diagnosis of a life-threatening
disease at a relatively young age can cause long-term psychological
distress (Schepisi et al., 2019).
Concern about care delivery was indicated by colorectal survi-
vors, especially at T2. This finding aligns with other studies (Russell
et al., 2015) but may reflect local services and not be generalisable.
Research in other locations has noted more unmet needs associated
with care delivery amongst breast than colorectal survivors (Wylie
et al., 2013).
The need to reduce stress in life was the second most frequently
cited need in all three tumour groups at T2. It was also in the top five
unmet needs for breast and testicular survivors at T0 (11th for colo-
rectal). Stress is also frequently cited as an unmet need in other stud-
ies (Brennan et al., 2016; Burris et al., 2015; Geller et al., 2014).
Feelings of stress in life might arise from factors unrelated to cancer,
but issues in early survivorship may provoke and exacerbate stress. In
the transition from patient to survivor post-treatment, interactions
with health care teams who have provided support diminish and assis-
tance from friends and family may also fade as pressure mounts for
the survivors to resume “normal” lives (Van Liew et al., 2014).
There is little comparative data available on testicular survivors
(White et al., 2012; Willems et al., 2015), but existing evidence sup-
ports the findings of this study that existential issues, such as fear of
recurrence and body image, are important (Bender et al., 2012; Smith
et al., 2013). Problems with sexual functioning post-treatment was an
emergent issue at T2 amongst testicular survivors, and a consistent
source of concern to breast and colorectal survivors. This can be
linked to body image changes, loss of confidence and problems restor-
ing intimate relationships (Matheson et al., 2016).
4.1 | Implications for practice
A challenge for health services is to balance resource constraints with
meeting the care needs of the rising cancer survivor population. Strat-
ified clinical pathways as implemented within the British NHS (NHS
Improvement, 2013) seek to target formal support on individuals with
the highest needs, offering continuing outpatient appointments to
selected survivors with health issues that are considered to warrant
ongoing clinical follow-up. For other survivors, emotional and
coping needs are addressed through supported self-management
programmes which provide generic information and advice on keeping
well and self-monitoring for signs of recurrence. In this study, survi-
vors with the highest number of unmet needs at T0 (and T2) reported
at least 10 (and 8) breast, 7 (and 5) colorectal and 7 (and 7) testicular,
suggesting significant negative impact on quality of life. About one
half of people with the highest number of needs at T0 were also
reporting the highest number of persistent needs at T2, the others at
T2 reporting emerging needs. Other mixed cancer studies confirm that
needs persist for many of the highest need survivors (Armes
et al., 2009; Valery et al., 2017). These findings indicate that some sur-
vivors experience significant problems in the early months after treat-
ment which can persist thereafter that warrant formal assessment
BATEHUP ET AL. 11 of 15
and monitoring. This may also affect individuals discharged for
self-care, as well as those receiving routine clinic follow up (Jefford
et al., 2013).
In terms of targeting the survivors at risk of having high numbers
of unmet needs, the findings of this study suggest that having had
chemotherapy was significant amongst breast and colorectal survi-
vors. Younger age was also important for the breast group. Higher
education was associated with more unmet needs for colorectal survi-
vors at T2 and marginally for breast survivors at T0. As an indicator of
more challenging disease, chemotherapy may give rise to higher anxi-
ety levels and result in a higher symptom burden extending into the
post-treatment phase. No characteristics were associated with higher
numbers of unmet needs amongst testicular survivors; however, the
sample was small. Unlike chemotherapy, adjuvant hormone therapy
was not associated with more unmet needs amongst breast survivors
even though this is both a reminder of the diagnosis and a cause of
side effects (Brennan et al., 2016).
Stress and coping issues are common in cancer survivors and can
significantly affect wellbeing (Geller et al., 2014). Little is known about
the value of routine clinic follow-up for meeting psycho-social needs,
and views may vary between individuals. Contact with health profes-
sionals may provide reassurance to some that is foregone in self-
management programmes. Alternatively, anticipation of hospital
appointments may be an unwanted reminder of cancer for others. A
recent study of men in the first 8 months after treatment for prostate
cancer concluded that supported self-management was at least
comparable (on various patient reported measures and unmet needs)
to appointment-based follow-up and cost neutral (Frankland
et al., 2019). Further in-depth analysis of expectations and experi-
ences is, however, warranted, with tracking of recurrence, survival
and adverse outcomes, as well as whole system costs, over a longer
period (Frankland et al., 2019).
Fear of recurrence was found to be the most common unmet
need and one that endures for all tumour groups. It is deemed “nor-
mal” amongst adults with a cancer history, and a degree of concern is
considered functional to prompt self-protective responses and staying
alert to signs of recurrence (Lebel et al., 2014). High or moderate
levels of anxiety, however, can negatively affect quality of life and
requires appropriate supportive care (Sarkar et al., 2015). Routine
clinic contact enables anxieties to be identified and addressed. Health
care teams can encourage disclosure, provide information and
respond to psychosocial aspects of fear, including referral to local
specialist resources if required. Some groups have been shown to
benefit from provision of a survivor care plan and a written summary
for self-management (Brennan et al., 2014; Howell et al., 2017;
Jefford et al., 2017). Mind–body interventions (such as cognitive-
behavioural and mindfulness) have also been found efficacious (Hall
et al., 2018) and targeted on line self-management interventions such
as ConquerFear (Butow et al., 2017; Smith et al., 2017), and
Mini-AFTERc (Davidson et al., 2018) can be integrated into specialist
nurse clinical practice. Follow-up has also been reported beneficial for
providing sexual function information and discussing relationship
issues (Averyt & Nishimoto, 2014; Brand et al., 2015) identified as
significant needs for some survivors in this study, with implications
for wellbeing and quality of life.
Contrary to other evidence reporting declining need for
emotional support over time amongst breast cancer survivors (Burris
et al., 2015), this study identified existential survivorship was a
continuing issue. Social support from family and friends is beneficial
to the psychological wellbeing of survivors (Smith et al., 2018), and
decreasing levels of social support after treatment have been linked
to reduced quality of life (Grimmett et al., 2017). Assessment of gaps
in support through follow-up, when survivors are searching for mean-
ing in their life, is relevant for all cancer survivors to instigate
signposting to support groups, or health and well-being programmes,
or referral to targeted professional input (Fenlon et al., 2015;
Grimmett et al., 2017).
Table 3 provides extensive information on observed change rates
in 25 different unmet needs for all three tumour groups, enabling
required sample sizes to be formulated for future studies seeking to
evaluate targeted interventions for specific needs.
5 | LIMITATIONS
There are several limitations to this study. The CaSUN survey
instrument was modified following patient feedback, but the changes
were minor and did not affect the scoring which followed rec-
ommended guidelines. Indeed, demonstrates that the five domains
behaved similarly across the three tumour sites confirming that the
modified tool performed consistently. The testicular sample was small
and the study ran out of time and resources such that some partici-
pants were not included in the follow-up data collection thereby
reducing the size of the sample in all three tumour groups at T2.
Moreover, follow-up was limited to 8 months whilst survivorship is
lifelong. Questionnaire responses included information on needs that
were met (80% of all reported needs), and these have not been
reported. Unmet needs of all strengths were combined in the analysis
without any weighting. The study was conducted in one health trust
in England, and findings may not be generalisable. The study com-
bined patients treated over a period in which follow-up protocols
were changing and by the end of the study 24% of participants were
in self-management follow up regimens. Comparison of the two
groups, however, found no difference at T0 nor in the subsequent
change in number of unmet needs from T0 at T2.
6 | CONCLUSIONS
This study contributes to the knowledge regarding unmet supportive
care needs of breast, colorectal and testicular cancer survivors early
after the end of treatment and two thirds of the way through their first
year. The results indicate that most survivors had few or no unmet
needs at the end of treatment or 8 months later but a small proportion
had significant numbers of persisting or emerging needs. Further
research is required to explore the long term clinical, psychosocial and
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economic implications of supported self-management programmes,
compared to clinic follow-up for different groups of cancer survivors.
Individual survivors have varying levels and types of needs and
personalised approaches to care are required. A recent analysis found
that individuals' background and presence of symptoms play a more
important role in the profile of unmet needs than cancer type
(Watanabe et al., 2020). Our study findings differ from those of others
in some respects but inconsistencies in evidence about unmet needs
have been widely reported (Puts et al., 2012; Willems et al., 2015). The
reasons for this also require investigation, including the extent to which
the differences reflect local factors and settings.
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